CLOSE

Motilal Oswal BSE Healthcare ETF

very highequityindex
47.69 0.97(2.08%) NAV as on 14 May 2026
10.79 % 1 M
11.78 % 1 Y
27.02 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

0.26

As on 30 Apr, 2026
Age :

3 yrs 9 m

Since 29 07 ,2022
Exit Load :

%

AUM :

41.85 Crs

Portfolio Price To Book Value :

6.89

Investing Style :

Large Growth

Min. Investment :

SIP NA & Lumpsum 500

Category :

etfs

Fund Manager :

Swapnil P Mayekar,Dishant Mehta,Rakesh Shetty

Launch Date :

29-Jul-22

Scheme Benchmark :

NA

FUND OBJECTIVE

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Apr 30 ,2026
Others 0.12 %
Equity 99.88 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.90 %
Divi's Laboratories Ltd.5.90 %
Dr. Reddy's Laboratories Ltd.5.74 %
Apollo Hospitals Enterprise Ltd.5.55 %
Cipla Ltd.5.28 %

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.74
Hospital & Healthcare Services22.18
Business Support1.14
Medical Equipment/Supplies/Accessories0.48
Miscellaneous0.17

5-YEARS HISTORY

Financial Year2022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)21.9635.3041.8142.30
Net Assets(Rs Crores) (as on 31-Mar-2026) 5.74 12.94 27.77 40.68
Scheme Returns(%)(Absolute)-4.1260.4117.052.62
B'mark Returns(%)(Absolute)NANANANA
Category Rank128/16023/20130/238118/323

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2025-20266.89-2.471.66-4.53
2024-20255.8419.442.30-8.40
2023-202417.9510.7610.6611.20
2022-2023NANA-1.34-4.83

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Motilal Oswal BSE Healthcare ETFVery HighEquity47.690.97(2.08%)NAV As on 14 May, 202629-Jul-2022Inception Date41.85AUM In Cr.11.78%1Y27.02%3YNA%5Y21.32%Since Inception
DSP Nifty 50 Equal Weight ETFVery HighEquity335.584.10(1.24%)NAV As on 14 May, 202608-Nov-2021Inception Date1,265.03AUM In Cr.6.02%1Y16.21%3YNA%5Y11.84%Since Inception
ICICI Pru Nifty 50 ETFVery HighEquity266.723.12(1.18%)NAV As on 14 May, 202620-Mar-2013Inception Date40,626.27AUM In Cr.-2.91%1Y10.16%3Y11.28%5Y12.67%Since Inception
Aditya Birla SL Nifty 50 ETFVery HighEquity27.590.32(1.18%)NAV As on 14 May, 202621-Jul-2011Inception Date3,102.28AUM In Cr.-2.88%1Y10.15%3Y11.28%5Y11.43%Since Inception
Nippon India ETF Nifty 50 BeESVery HighEquity268.093.13(1.18%)NAV As on 14 May, 202628-Dec-2001Inception Date62,881.14AUM In Cr.-2.92%1Y10.15%3Y11.27%5Y14.95%Since Inception
UTI Nifty 50 ETFVery HighEquity260.913.05(1.18%)NAV As on 14 May, 202601-Sep-2015Inception Date69,606.75AUM In Cr.-2.90%1Y10.14%3Y11.26%5Y12.21%Since Inception

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd